Pfizer to Pay $67.5 Million for Misleading Investors About Medication Risks

Pfizer pharmaceuticals has agreed to settle with former shareholders of subsidiary Wyeth Pharmaceuticals regarding Wyeth’s failure to reveal adverse effects of its antidepressant drug Pristiq.

Article →